Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment

Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment

Purpose. The patient’s perspective is becoming increasingly important in clinical and policy decisions. This study examined atrial fibrillation (AF) patient preferences for different characteristics of nonvitamin K antagonist oral anticoagulants (NOACs). Methods. A discrete choice experiment (DCE) a...

Full description

Bibliographic Details
Main Authors:	Thomas Wilke, Anna-Katharina Meinecke, Bernhard Schaefer, Sandra Buchwald, Daniel Eriksson, Sabrina Müller
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Cardiology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2019/5719624

Similar Items

Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants
by: Yoshinari Morimoto, et al.
Published: (2016-03-01)

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
by: Blann A
Published: (2015-08-01)

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
by: Jan Beyer-Westendorf, et al.
Published: (2021-07-01)

Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants
by: Lessire Sarah, et al.
Published: (2014-01-01)

Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”
by: Sarah Lessire, et al.
Published: (2014-01-01)

Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?
by: Jong S. Kim
Published: (2019-09-01)

Female Sex as a Thromboembolic Risk Factor in the Era of Nonvitamin K Antagonist Oral Anticoagulants
by: Mariacarla Gallù, et al.
Published: (2020-01-01)

The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants
by: Jamshed Dalal, et al.
Published: (2015-12-01)

The change of renal functions after nonvitamin K oral anticoagulants in patients with atrial fibrillation
by: Thoranis Chantrarat, et al.
Published: (2021-08-01)

Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants
by: Kyohei Maruyama, et al.
Published: (2018-01-01)

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study
by: Sola Han, et al.
Published: (2021-08-01)

Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS score ⩾ 2
by: Maria M Fernandez, et al.
Published: (2015-11-01)

No Such Thing as a Free-Rider? Understanding Drivers of Childhood and Adult Vaccination through a Multicountry Discrete Choice Experiment
by: Frederik Verelst, et al.
Published: (2021-03-01)

Multicountry and Regional Macroeconometric Models
by: Władysław Welfe
Published: (2012-12-01)

Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment
by: Ken Okumura, et al.

Measuring stroke patients’ exercise preferences using a discrete choice experiment
by: Wolfgang Geidl, et al.
Published: (2018-03-01)

Prevalence of nonvitamin, nonmineral supplement usage among students in a Turkish university
by: Son Osman, et al.
Published: (2005-05-01)

Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
by: Joong Hyun Park, et al.
Published: (2018-12-01)

The selection problem for Multicountry Consolidation hub port
by: Chih-Hung Chang, et al.
Published: (2003)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
by: Heng Cai, et al.
Published: (2020-01-01)

How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians’ Preferences
by: Müller S, et al.
Published: (2020-02-01)

Risk of recurrent stroke for Asian stroke patients treated with non-vitamin K antagonist oral anticoagulant and warfarin
by: Sheng-Feng Lin, et al.
Published: (2020-11-01)

Nonvitamin, Nonmineral Dietary Supplement Use among Adults with Fibromyalgia: United States, 2007–2012
by: Termeh Feinberg, et al.
Published: (2017-01-01)

Currency Risk Factors in a Recursive Multicountry Economy
by: Colacito, R., et al.
Published: (2018)

ENVIRONMENT AND INTERNATIONAL TRADE: A MULTICOUNTRY EMPIRICAL STUDY
by: Ilechukwu, Nneamaka I
Published: (2021)

Preferences of Patients with Chronic Hepatitis B – A Discrete Choice Experiment on the Acceptability of Functional Cure
by: Hardtstock F, et al.
Published: (2020-03-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Preferences for work arrangements: A discrete choice experiment.
by: Peter Valet, et al.
Published: (2021-01-01)

Cultural and Socioeconomic Determinants of Invention: A Multicountry, Multiperiod Analysis
by: Moshin Habib, et al.
Published: (2001-03-01)

Patient Preferences in Adjuvant and Palliative Treatment of Advanced Melanoma: A Discrete Choice Experiment
by: Juliane Weilandt, et al.
Published: (2020-03-01)

Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants
by: Jan C. Purrucker, et al.
Published: (2017-01-01)

Anticoagulants in clinical practice. The place of vitamin K antagonists in combination with new oral anticoagulants
by: T. V. Vavilova
Published: (2015-12-01)

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01)

Discrete-choice modelling of patient preferences for modes of drug administration
by: Ebenezer Kwabena Tetteh, et al.
Published: (2017-07-01)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
by: Maura Poli, et al.
Published: (2017-04-01)

Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke
by: Luís Paiva, et al.
Published: (2021-05-01)

Non-Vitamin K Antagonist Oral Anticoagulants A Concise Guide
Published: (2016)

Patient Preferences For Specialty Pharmacy Services: A Stated Preference Discrete-Choice Experiment in China
by: Qinyuan Hu, et al.
Published: (2020-12-01)

Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients
by: Taizen Nakase, et al.
Published: (2018-01-01)

MRI characteristics in acute ischemic stroke patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists
by: Thomas Raphael Meinel, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_pcfp2h49qoh9fbigl05bj0ote5